1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Implications of Race and Ethnicity in Sarcopenia US National Prevalence of Sarcopenia by Muscle Mass, Strength, and Function Indices

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sarcopenia prevalence varies widely by definitions and populations, which led to the creation of new criteria by the Sarcopenia Definitions and Outcomes Consortium. Yet, the degree to which sarcopenia prevalence varies according to these criteria across race and ethnic groups in the U.S. population needs further investigation. We estimated the US national prevalence of sarcopenia using different indices among adults aged 50–80 years across race and ethnicity groups utilizing data from the National Health and Nutrition Examination Surveys (NHANES: 1999–2002 and 2011–2014). Sarcopenia was defined by appendicular lean mass divided by body mass index (ALM/BMI), grip strength, and gait speed. For each index the following samples were constructed: grip strength (NHANES 2011–2014: N=4,615), gait speed (NHANES 1999–2002: N=3,448) and ALM/BMI (NHANES 1999–2002: N=3,448) among adults aged 50–80 years. Sarcopenia prevalence varied by race/ethnicity: NH-Whites (11.2–24.3%), Hispanics (21.9–36.0%), NH-Blacks (4.4–27.7%), and Asians/others (18.5–35.7%). Based on the multivariable models, compared to NH-Whites, NH-Blacks were less likely to have sarcopenia by ALM/BMI (OR=0.26, 95%CI: 0.18–0.39), and more likely by gait speed (OR=3.90, 95% CI: 3.00–5.06) with no difference by grip strength (OR=0.96, 95%CI: 0.75–1.24). While, Hispanics and Asians/others were more likely to have sarcopenia by grip strength, gait speed, and ALM/BMI (ORs=2.15–3.21) compared to NH-Whites. This study suggests the need for inclusion of race/ethnicity related criteria in sarcopenia definitions. Future investigations could determine whether this discrepancy between race/ethnicity across sarcopenia indices, particularly in NH-Blacks, is partly due to either muscle mass or functional changes with aging.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Sarcopenia: revised European consensus on definition and diagnosis

          doi: 10.1093/ageing/afy169 In the original version of the above paper there was an error in Table 3, which shows the recommended cut-off points for ASM/height2 in women. The cut-off point was given as <6.0 kg/m2, but the correct value is <5.5 kg/m2. This has now been corrected online. The authors wish to apologise for this error.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)

            Objective: to examine the clinical evidence reporting the prevalence of sarcopenia and the effect of nutrition and exercise interventions from studies using the consensus definition of sarcopenia proposed by the European Working Group on Sarcopenia in Older People (EWGSOP). Methods: PubMed and Dialog databases were searched (January 2000–October 2013) using pre-defined search terms. Prevalence studies and intervention studies investigating muscle mass plus strength or function outcome measures using the EWGSOP definition of sarcopenia, in well-defined populations of adults aged ≥50 years were selected. Results: prevalence of sarcopenia was, with regional and age-related variations, 1–29% in community-dwelling populations, 14–33% in long-term care populations and 10% in the only acute hospital-care population examined. Moderate quality evidence suggests that exercise interventions improve muscle strength and physical performance. The results of nutrition interventions are equivocal due to the low number of studies and heterogeneous study design. Essential amino acid (EAA) supplements, including ∼2.5 g of leucine, and β-hydroxy β-methylbutyric acid (HMB) supplements, show some effects in improving muscle mass and function parameters. Protein supplements have not shown consistent benefits on muscle mass and function. Conclusion: prevalence of sarcopenia is substantial in most geriatric settings. Well-designed, standardised studies evaluating exercise or nutrition interventions are needed before treatment guidelines can be developed. Physicians should screen for sarcopenia in both community and geriatric settings, with diagnosis based on muscle mass and function. Supervised resistance exercise is recommended for individuals with sarcopenia. EAA (with leucine) and HMB may improve muscle outcomes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis

              Objective The purpose of this study was to perform a systematic review to assess the short-, middle- and long-term consequences of sarcopenia. Methods Prospective studies assessing the consequences of sarcopenia were searched across different electronic databases (MEDLINE, EMBASE, EBM Reviews, Cochrane Database of Systematic Reviews, EBM Reviews ACP Journal Club, EBM Reviews DARE and AMED). Only studies that used the definition of the European Working Group on Sarcopenia in Older People to diagnose sarcopenia were included. Study selection and data extraction were performed by two independent reviewers. For outcomes reported by three or more studies, a meta-analysis was performed. The study results are expressed as odds ratios (OR) with 95% CI. Results Of the 772 references identified through the database search, 17 were included in this systematic review. The number of participants in the included studies ranged from 99 to 6658, and the duration of follow-up varied from 3 months to 9.8 years. Eleven out of 12 studies assessed the impact of sarcopenia on mortality. The results showed a higher rate of mortality among sarcopenic subjects (pooled OR of 3.596 (95% CI 2.96–4.37)). The effect was higher in people aged 79 years or older compared with younger subjects (p = 0.02). Sarcopenia is also associated with functional decline (pooled OR of 6 studies 3.03 (95% CI 1.80–5.12)), a higher rate of falls (2/2 studies found a significant association) and a higher incidence of hospitalizations (1/1 study). The impact of sarcopenia on the incidence of fractures and the length of hospital stay was less clear (only 1/2 studies showed an association for both outcomes). Conclusion Sarcopenia is associated with several harmful outcomes, making this geriatric syndrome a real public health burden.
                Bookmark

                Author and article information

                Journal
                9918351188206676
                51424
                Gerontol Geriatr Res
                Gerontol Geriatr Res
                Gerontology and geriatric research
                2733-2292
                10 March 2022
                2021
                16 April 2021
                31 March 2022
                : 4
                : 1
                : 126
                Affiliations
                [1 ]The Baltimore Geriatric Research, Education and Clinical Center, Veterans Affairs Maryland Health Care System, Baltimore, USA
                [2 ]Department of Medicine at the University of Maryland School of Medicine, Division of Gerontology and Palliative Medicine, USA
                Author notes
                Corresponding author: Ryan AS, Department of Medicine at the University of Maryland School of Medicine, 10 North Greene St, BT/18/GR, Baltimore USA, Tel: +410-605-7851; Fax: +410-605-7913; aryan@ 123456som.umaryland.edu
                Article
                NIHMS1781848
                8970578
                35368515
                8976f249-8be6-4d96-b85c-3b28cb943f7c

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Categories
                Article

                sarcopenia,race/ethnicity,gait speed,grip strength,appendicular lean mass

                Comments

                Comment on this article